Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/06/2014US20140328944 USE OF CTBP1 siRNA FOR THE TREATMENT OF GASTRIC CANCER
11/06/2014US20140328940 Modulation of axon degeneration
11/06/2014US20140328937 Drug Delivery Systems and Use Thereof
11/06/2014US20140328936 Novel pharmaceutical statin composition
11/06/2014US20140328934 Granules for pharmaceutical preparations, methods and apparatus for their production
11/06/2014US20140328932 Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity
11/06/2014US20140328931 Nucleic acid particles, methods and use thereof
11/06/2014US20140328930 Pharmaceutical Compositions
11/06/2014US20140328929 Method of Preventing Acute Graft-Versus-Host Disease using Oral Beclomethasone Dipropionate
11/06/2014US20140328928 Stable Aqueous Suspension
11/06/2014US20140328926 Modified hyaluronic acid polymer compositions and related methods
11/06/2014US20140328925 Micronized tanaproget, compositions, and methods of preparing the same
11/06/2014US20140328924 Delivery of immunosuppressants having a specified pharmacodynamic effective-life and antigen for the induction of immune tolerance
11/06/2014US20140328923 Dosing combinations for reducing undesired humoral immune responses
11/06/2014US20140328921 Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
11/06/2014US20140328920 System for the delivery of biologically active compounds into an organism and method for the preparation of said system
11/06/2014US20140328919 Polymer-agent conjugates, particles, compositions, and related methods of use
11/06/2014US20140328918 Methods of treating a subject and related particles, polymers and compositions
11/06/2014US20140328917 Organic compound nano-powder, method for producing the same and suspension
11/06/2014US20140328915 Dosage form for insertion into the mouth
11/06/2014US20140328913 Rapidly disintegrating gelatinous coated tablets
11/06/2014US20140328912 Delayed Release Tablet With Defined Core Geometry
11/06/2014US20140328911 Compositions comprising pomegranate polyphenols in combination with erectile dysfunction-treating compounds, and methods of treating erectile dysfunction therewith
11/06/2014US20140328910 Ingestion method of creatine composition, creatine composition for using in the ingestion method, and creatine-containing medicament and food each produced using the creatine composition
11/06/2014US20140328909 Krill oil and reacted astaxanthin composition and associated method
11/06/2014US20140328908 Controlled-release formulation
11/06/2014US20140328906 Methods of Treating Impaired Glucose Metabolism via Administration of Algal Biomass
11/06/2014US20140328904 Gla monotherapy for use in cancer treatment
11/06/2014US20140328902 Antimicrobials and methods of use thereof for wound healing
11/06/2014US20140328899 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
11/06/2014US20140328897 Charge triggering of self-organized nanoparticles
11/06/2014US20140328896 Compositions and methods for modifying gastrointestinal flora
11/06/2014US20140328895 Film-forming composition for a ph-dependant sustained release of the active agent
11/06/2014US20140328893 Nutlin compounds for use in the treatment of pulmonary hypertension
11/06/2014US20140328892 Use of alfimeprase in the treatment of thrombosis
11/06/2014US20140328885 Sheet for cutaneous application containing vitamin e or an ester thereof
11/06/2014US20140328863 Induction of Differential Stress Resistance and Uses Thereof
11/06/2014US20140328861 Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
11/06/2014US20140328860 Methods for stimulating hematopoietic recovery by inhibiting tgf beta signaling
11/06/2014US20140328859 Antibodies and methods for wnt pathway-related diseases
11/06/2014US20140328854 Tolerogenic synthetic nanocarriers and therapeutic macromolecules for reduced or enhanced pharmacodynamic effects
11/06/2014US20140328853 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
11/06/2014US20140328840 Marker and target for responsiveness and resistance to cancer agents
11/06/2014US20140328835 Methods for treating retinopathy with extended therapeutic effect
11/06/2014US20140328834 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
11/06/2014US20140328832 Methods for treating cancer using combination therapy
11/06/2014US20140328828 Use of therapeutic compositions comprising hyaluronan and therapeutic antibodies
11/06/2014US20140328827 Methods for Fucoidan Purification from Seaweed Extracts
11/06/2014US20140328826 Product and method for treating keloid scars, hypertrophic scars and burn scars with contracture
11/06/2014US20140328824 Diagnostic and Therapeutic Methods and Their Application in Amyotrophic Lateral Sclerosis (ALS)
11/06/2014US20140328823 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
11/06/2014US20140328813 Combination Bacteriolytic Therapy for the Treatment of Tumors
11/06/2014US20140328809 Methods of inducing chondrogenesis in mesenchymal stem cells using synthetic triterpenoids
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/06/2014US20140328799 Compositions useful for the treatment of viral diseases
11/06/2014US20140328798 Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
11/06/2014US20140328795 Virucidal small molecule and uses thereof
11/06/2014US20140328793 Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
11/06/2014US20140328792 Methods and compositions for treating and preventing viral infections
11/06/2014US20140328789 pH-RESPONSIVE CELL SCAFFOLD AND METHOD OF USING SAME
11/06/2014US20140328782 Peptide inhibiting matrix metalloproteanases activity and use thereof
11/06/2014US20140328778 Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis
11/06/2014US20140328777 Sunscreens
11/06/2014US20140328770 Topical tetracycline compositions
11/06/2014US20140328759 Limit size lipid nanoparticles and related methods
11/04/2014US8877980 Phenylboronic acid
11/04/2014US8877975 Cycloalkylamines as monoamine reuptake inhibitors
11/04/2014US8877970 Inhibitors of carbonic anhydrase IX
11/04/2014US8877968 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/04/2014US8877949 Furo[3,2-g]chromene compounds and uses thereof
11/04/2014US8877946 Benzylidene-indolinone compounds and their medical use
11/04/2014US8877944 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors
11/04/2014US8877940 Antibiotic tolerance inhibitors
11/04/2014US8877938 Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
11/04/2014US8877935 One-pot process for the synthesis of dalfampridine
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877933 Thermodynamically stable form of a tosylate salt
11/04/2014US8877932 Anhydrous lenalidomide form-I
11/04/2014US8877928 Pegylated cyclopamine analogue, preparation method and uses thereof
11/04/2014US8877927 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
11/04/2014US8877906 Amphiphiles for protein solubilization and stabilization
11/04/2014US8877902 Formulations and methods for weight loss and body contouring
11/04/2014US8877899 Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
11/04/2014US8877890 Melanocortin-1 receptor-specific cyclic peptides
11/04/2014US8877820 Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
11/04/2014US8877819 Methods for treating heat stress and related compositions
11/04/2014US8877817 Stable ready to use injectable paracetamol formulation
11/04/2014US8877816 4-(or 5-) substituted catechol derivatives
11/04/2014US8877815 Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
11/04/2014US8877814 Titration package for neramexane and its use in the treatment of an inner ear disorder
11/04/2014US8877813 Antiinflammatory and analgesic preparation for external use
11/04/2014US8877812 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
11/04/2014US8877811 Hypoglycemic oral drug for treating non-insulin dependent and insulin dependent diabetes
11/04/2014US8877810 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt
11/04/2014US8877809 Compositions and methods for treating macular degeneration
11/04/2014US8877808 Protection against skin diseases by aurin tricarboxylic acid and its derivatives
11/04/2014US8877807 Compositions and methods for reducing body fat
11/04/2014US8877806 Treatment of sleep-wake disorders
11/04/2014US8877805 Heteroarylcarboxylic acid ester derivative
11/04/2014US8877804 Sulfur derivatives as chemokine receptor modulators
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 7860